CONTROLLED SUBSTANCES ACT

Bills and resolutions

DEA: improve regulation of anabolic steroids (see S. 2012), S890 [11FE] (see H.R. 4771), H5022 [29MY]

Dept. of Justice: exempt certain products from Controlled Substances Act requirements on scheduled listed chemicals if it is not practical to use such products in illicit manufacture of methamphetamine (see H.R. 4502), H3240 [28AP]

——— improve enforcement efforts relative to prescription drug diversion and abuse (see H.R. 4069), H1780 [18FE] (see H.R. 4709), H4784 [21MY]

Drugs: exclude therapeutic hemp and cannabidiol from the definition of marijuana (see H.R. 5226), H6976 [28JY]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (see S. 2862), S5782 [18SE] (see H.R. 4299), H2694 [26MR]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (see H.R. 4975), H5768 [25JN]

——— increase access to opioid addiction treatment by expanding ability of medical professionals to provide medication-assisted therapies (see S. 2645), S4762 [23JY]

——— increase number of opioid abusing or addicted patients that providers may treat in an outpatient setting and allow qualified nurse practitioners and physician assistants to treat such patients (see S. 2825), S5628 [16SE]

——— provide for legitimate use of medicinal marijuana in accordance with State laws (see H.R. 4498), H3240 [28AP]

Letters

Ensuring Patient Access and Effective Drug Enforcement Act: Representative Goodlatte, Committee on the Judiciary (House), H7005 [29JY]

——— Representative Upton, Committee on Energy and Commerce (House), H7005 [29JY]

Veterinary Medicine Mobility Act: Representative Goodlatte, Committee on the Judiciary (House), H5835 [8JY]

——— Representative Upton, Committee on Energy and Commerce (House), H5835 [8JY]

Remarks in House

DEA: improve regulation of anabolic steroids (H.R. 4771), H7459–H7461 [15SE]

Dept. of Justice: condition reduction of Deputy Attorney General Office salaries account funding on enforcement of Federal laws relative to marijuana use, H4906–H4908 [28MY]

——— improve enforcement efforts relative to prescription drug diversion and abuse (H.R. 4709), H7004–H7007 [29JY]

Drugs: focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses, E339 [10MR]

——— prohibit Federal prosecution of residents who are acting in accordance with their State’s marijuana laws (H.R. 1523), H2659 [26MR], H7992 [14NO]

——— reschedule marijuana under the Controlled Substances Act and allow for medicinal use of marijuana in accordance with State laws, H2995 [8AP], H4053–H4055 [9MY]

Holder, Attorney General: impeach (H. Res. 411), H6663 [23JY]

U.S. Sentencing Commission: decision to retroactively modify sentencing guidelines for certain drug offenses, E1203 [22JY]

Veterinarians: allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (H.R. 1528), H5834–H5836 [8JY]

Remarks in Senate

DEA: improve regulation of anabolic steroids (H.R. 4771), S6696 [11DE]

——— improve regulation of anabolic steroids (S. 2012), S891 [11FE]

——— issuance of final rule implementing the Secure and Responsible Drug Disposal Act, S1905 [1AP]

Drugs: address sentencing disparity between crack and powder cocaine, S4143 [26JN]

——— focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (S. 1410), S2224–S2226 [8AP], S2942 [13MY], S3912 [24JN], S4449 [14JY], S5845 [18SE], S6490 [10DE]

——— place synthetic drugs in Schedule I indicating high potential for abuse, no current accepted medical use, and lack of accepted safety for use under medical supervision, S1580 [12MR]

Veterinarians: allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (H.R. 1528), S4567, S4568 [16JY]

——— allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (S. 1171), S185 [8JA]

Reports filed

Designer Anabolic Steroid Control Act: Committee on Energy and Commerce (House) (H.R. 4771) (H. Rept. 113–587), H7527 [15SE]

——— Committee on the Judiciary (House) (H.R. 4771) (H. Rept. 113–587), H7527 [15SE]

Ensuring Patient Access and Effective Drug Enforcement Act: Committee on Energy and Commerce (House) (H.R. 4709) (H. Rept. 113–605), H7881 [18SE]

Improving Regulatory Transparency for New Medical Therapies Act: Committee on Energy and Commerce (House) (H.R. 4299) (H. Rept. 113–565), H7038 [29JY]

——— Committee on the Judiciary (House) (H.R. 4299) (H. Rept. 113–565), H7900 [19SE]

Smarter Sentencing Act: Committee on the Judiciary (Senate) (S. 1410), S1517 [11MR]

Veterinary Medicine Mobility Act: Committee on Energy and Commerce (House) (H.R. 1528) (H. Rept. 113–457), H4683 [20MY]

Texts of

H.R. 1528, Veterinary Medicine Mobility Act, H5834 [8JY]

H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act, H7004 [29JY]

H.R. 4771, Designer Anabolic Steroid Control Act, H7459 [15SE]

S. 1171, allow veterinarians to transport and dispense controlled substances in the usual course of veterinary practice outside of the registered location, S185 [8JA]